血浆心型脂肪酸结合蛋白、omega-3脂肪酸与普通人群不良心脏事件
结果显示H-FABP升高与冠心病、心梗、冠心病死亡和心衰风险增加相关,且该关联在omega-3脂肪酸水平较低者中更为显著。
要点
- H-FABP升高与冠心病、心梗、冠心病死亡和心衰风险增加独立相关。
- omega-3脂肪酸水平修饰H-FABP与冠心病、心梗的关联,低水平者风险更高。
- H-FABP或可作为普通人群长期心脏事件风险评估的潜在生物标志物。
核心结论
- 普通人群中血浆H-FABP水平升高与冠心病和心衰风险增加相关,尤其在omega-3脂肪酸水平较低个体中更为明显。
主要发现
- H-FABP最高三分位组较最低三分位组冠心病风险HR为1.29,心梗HR为1.54,冠心病死亡HR为2.04,心衰HR为1.95,所有P-trend均<0.001。
- omega-3脂肪酸对H-FABP与冠心病的关联存在交互作用(P-interaction=0.014),对心梗的交互作用P-interaction=0.003。
- 在omega-3脂肪酸较低者中,H-FABP极端三分位组冠心病HR为1.41(95%CI 1.15-1.74),心梗HR为2.23(95%CI 1.57-3.15)。
- 在omega-3脂肪酸较高者中,H-FABP极端三分位组冠心病HR为1.15(95%CI 0.96-1.38),心梗HR为1.11(95%CI 0.83-1.50)。
临床怎么用
- 在普通人群心血管风险评估中,可考虑检测血浆H-FABP以识别冠心病和心衰高风险个体。
- 对于H-FABP升高者,评估omega-3脂肪酸水平可能有助于进一步分层风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart-type fatty acid-binding protein (H-FABP), a principal intracellular transporter of long-chain fatty acids (FAs), has been investigated as an early diagnostic biomarker for acute myocardial infarction (MI) and acute coronary syndrome. However, evidence regarding its associations with long-term risk of cardiac events and potential interaction with omega-3 FAs remains scarce. Therefore, we aimed to investigate these associations in the general population. METHODS: This study included 42 392 participants from the UK Biobank who were free of coronary heart disease (CHD) and heart failure (HF) at baseline. Plasma levels of H-FABP were quantified using the Olink platform. Multivariable Cox regression was used to evaluate the associations of H-FABP with incident CHD and HF, considering potential interaction with omega-3 FAs. RESULTS: Elevated H-FABP levels were consistently associated with a higher risk of CHD (HR T3 vs T1=1.29), MI (HR T3 vs T1=1.54), CHD-related mortality (HR T3 vs T1=2.04) and HF (HR T3 vs T1=1.95) (all P-trend values <0.001). These associations appeared to be modified by plasma levels of omega-3 FAs, especially so for CHD (P-interaction=0.014) and MI (P-interaction=0.003). Comparing the extreme tertiles of H-FABP, HRs (95% CI) of CHD and MI were 1.41 (1.15 to 1.74) and 2.23 (1.57 to 3.15), respectively, among participants with lower omega-3 FAs, and 1.15 (0.96 to 1.38) and 1.11 (0.83 to 1.50), respectively, among those with higher omega-3 FAs. CONCLUSIONS: Higher plasma levels of H-FABP were associated with a higher risk of CHD and HF in the general population, predominantly among individuals with low levels of omega-3 FAs.
引用
- Lyu, Qian, Xu, et al. Plasma heart-type fatty acid-binding protein, omega-3 fatty acids and adverse cardiac events in the general population. Heart. 2026. PMID: 42823338. doi:10.1136/heartjnl-2026-327893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。